aldosterone has been researched along with Liver Diseases, Alcoholic in 4 studies
Liver Diseases, Alcoholic: Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Midodrine and octreotide were dosed to obtain a stable increase of at least 15 mm Hg of mean arterial pressure." | 6.69 | Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. ( Amodio, P; Angeli, P; Caregaro, L; Craighero, R; Gatta, A; Gerunda, G; Maffei-Faccioli, A; Merenda, R; Roner, P; Sticca, A; Volpin, R, 1999) |
| " Midodrine and octreotide were dosed to obtain a stable increase of at least 15 mm Hg of mean arterial pressure." | 2.69 | Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. ( Amodio, P; Angeli, P; Caregaro, L; Craighero, R; Gatta, A; Gerunda, G; Maffei-Faccioli, A; Merenda, R; Roner, P; Sticca, A; Volpin, R, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angeli, P | 1 |
| Volpin, R | 1 |
| Gerunda, G | 1 |
| Craighero, R | 1 |
| Roner, P | 1 |
| Merenda, R | 1 |
| Amodio, P | 1 |
| Sticca, A | 1 |
| Caregaro, L | 1 |
| Maffei-Faccioli, A | 1 |
| Gatta, A | 1 |
| Mitch, WE | 1 |
| Whelton, PK | 1 |
| Cooke, CR | 1 |
| Walker, WG | 1 |
| Maddrey, WC | 1 |
| Borodulin, VG | 1 |
| Zubovskiĭ, GA | 1 |
| Avdienko, VN | 1 |
| Kawasaki, H | 1 |
| Uemasu, J | 1 |
| Maeda, N | 1 |
| Hirayama, C | 1 |
| Kobayashi, T | 1 |
| Sakurai, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Vasoconstrictors as Alternatives to Albumin After Large Volume Paracentesis in Cirrhosis[NCT00108355] | Phase 4 | 29 participants (Actual) | Interventional | 2003-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Defined as an increase in Plasma Renin Activity (PRA) by >50% from baseline to a level > 4 ng/mL/h at post-paracentesis day (NCT00108355)
Timeframe: 6 days after paracentesis
| Intervention | participants (Number) |
|---|---|
| Albumin (Control Group) | 2 |
| Vasoconstrictor (Treatment Group) | 2 |
Comparison between Albumin (Control group) and Vasoconstrictor (Treatment group) (NCT00108355)
Timeframe: Variable depending on the patient, average 10 days
| Intervention | days (Median) |
|---|---|
| Albumin (Control Group) | 10 |
| Vasoconstrictor (Treatment Group) | 8 |
2 trials available for aldosterone and Liver Diseases, Alcoholic
| Article | Year |
|---|---|
Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
Topics: Aldosterone; Ascites; Blood Pressure; Diuresis; Electrolytes; Gastrointestinal Agents; Glomerular Fi | 1999 |
Plasma levels and hepatic extraction of renin and aldosterone in alcoholic liver disease.
Topics: Adult; Aldosterone; Female; Humans; Liver; Liver Diseases, Alcoholic; Male; Middle Aged; Prednisolon | 1979 |
2 other studies available for aldosterone and Liver Diseases, Alcoholic
| Article | Year |
|---|---|
[Functional state of the hypophyseo-adrenal system in patients with chronic alcoholism and various degrees of liver damage].
Topics: Adrenocorticotropic Hormone; Adult; Alcoholism; Aldosterone; Humans; Hydrocortisone; Liver Diseases, | 1988 |
Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
Topics: Aldosterone; Atrial Natriuretic Factor; Carcinoma, Hepatocellular; Chronic Disease; Female; Hepatiti | 1987 |